Drugs of Abuse: The Highs and Lows of Altered Mental States in the Emergency Department

Emergency Medicine Clinics of North America

Volumn 28, Issue 3, 2010, Pages 663-682

  Meehan, Timothy J ^a,b   Bryant, Sean M ^a,c,d   Aks, Steven E ^a,c,e  

^a Toxikon Consortium   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^c Jr Hospital of Cook County   (United States)

^d ILLINOIS POISON CENTER   (United States)

^e RUSH MEDICAL COLLEGE   (United States)

Author keywords

Emergency department; Malicious intoxication; Seizure; Toxidrome

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; CHOLINERGIC RECEPTOR BLOCKING AGENT; COCAINE; DEXTROPROPOXYPHENE; FLUMAZENIL; HYPNOTIC SEDATIVE AGENT; LYSERGIDE; MESCALINE; METHYLXANTHINE DERIVATIVE; NALOXONE; NARCOTIC ANALGESIC AGENT; PETHIDINE; PHENCYCLIDINE; PHYSOSTIGMINE; PSILOCIN; PSILOCYBINE; PSYCHEDELIC AGENT;

ATAXIA; BRAIN INJURY; DISEASE SEVERITY; DIZZINESS; DRUG ABUSE; DRUG CLASSIFICATION; DRUG DEPENDENCE; DRUG DETOXIFICATION; DRUG INTOXICATION; EMERGENCY WARD; HEADACHE; HUMAN; HYPERTENSION; MENTAL DISEASE; MENTAL HEALTH; MUSHROOM POISONING; PATIENT ASSESSMENT; PRIORITY JOURNAL; REVIEW; SEIZURE; TACHYCARDIA;

EID: 77955631531     PISSN: 07338627     EISSN: 07338627     Source Type: Journal    
DOI: 10.1016/j.emc.2010.03.012     Document Type: Review

References (63)

1. Langman L.J., Kapur B.M. Toxicology: then and now. Clin Biochem 2006, 39:498-510.
2. Hammett-Stabler C.A., Pesce A.J., Cannon D.J. Urine drug screening in the medical setting. Clin Chim Acta 2002, 315:125-135.
3. Beverly R. History and present state of Virginia 1855, JW Randolph, Richmond (VA).
4. Sopchak C.A., Stork C.M., Cantor R.M. Central anticholinergic syndrome due to Jimson weed: physostigmine therapy revisited. Clin Toxicol 1998, 36:43-45.
5. Klein-Schwartz W., Oderda G.M. Jimsonweed intoxication in adolescents and young adults. Am J Dis Child 1984, 138:737-739.
6. Pereira C.A., Nishioka S.A. Poisoning by the use of Datura leaves in a homemade toothpaste. Clin Toxicol 1994, 32:329-331.
7. Jones J., Dougherty J., Cannon L. Diphenhydramine-induced toxic psychosis. Am J Emerg Med 1982, 4:369.
8. Yokoyama H., Sato M., Linuma K., et al. Centrally acting histamine H1 antagonists promote the development of amygdala kindling in rats. Neurosci Lett 1996, 217(2-3):194-196.
9. Kamei C., Ohuchi M., Sugimoto Y., et al. Mechanism responsible for epileptogenic activity by first generation H1 antagonists in rats. Brain Res 2000, 887(1):183-186.
10. Wills B., Erickson T. Drug and toxin associated seizures. Med Clin North Am 2005, 89:1297-1321.
11. Dubin W.R., Feld J.A. Rapid tranquilization of the violent patient. Am J Emerg Med 1989, 7:313.
12. Pentel P., Peterson C.D. Asystole complicating physostigmine treatment of tricyclic antidepressant overdose. Ann Emerg Med 1980, 9:588.
13. Suchard J.R. Assessing physostigmine's contraindication in cyclic antidepressant ingestions. J Emerg Med 2003, 25:185-191.
14. Schneir A.B., Offerman S.R., Ly B.T., et al. Complications of diagnostic physostigmine administration to emergency department patients. Ann Emerg Med 2003, 42:14-19.
15. Burns M.J., Linden C.H., Graudins A., et al. A comparison of physostigmine and benzodiazepines for the treatment of anticholinergic poisoning. Ann Emerg Med 1999, 35:374-381.
16. The National Institutes for Drug Abuse Cocaine: abuse and addiction Available at:, Accessed October 8, 2009. http://www.nida.nih.gov/researchreports/cocaine/cocaine.html.
17. Bourland J.A., Martin D.K., Mayersohn M. In vitro transesterification of cocaethylene (ethylcocaine) in the presence of ethanol. esterase-mediated ethyl ester exchange esterase-mediated ethyl ester exchange. Drug Metab Dispos 1998, 26:203-206.
18. Callaway C.W., Clark R.F. Hyperthermia in psychostimulant overdose. Ann Emerg Med 1994, 24(1):68-76.
19. McCord J., Jneid H., Hollander J.E., et al. American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology, Management of cocaine-associated chest pain and myocardial infarction: a scientific statement from the American Heart Association Acute Cardiac Care Committee of the Council on Clinical Cardiology. Circulation 2008, 117(14):1897-1907.
20. Petitti D.B., Sidney S., Quesenberry C., et al. Stroke and cocaine or amphetamine use. Epidemiology 1998, 9(6):596-600.
21. Levine S.R., Brust J.C., Futrell N., et al. A comparative study of the cerebrovascular complications of cocaine: alkaloidal versus hydrochloride - a review. Neurology 1991, 41(8):1173-1177.
22. Farooq M.U., Bhatt A., Patel M. Neurotoxic and cardiotoxic effects of cocaine and ethanol. J Med Toxicol 2009, 5(3):134-138.
23. Merkel P.A., Koroshetz W.J., Irizarry M.C., et al. Cocaine-associated cerebral vasculitis. Semin Arthritis Rheum 1995, 25(3):172-183.
24. Boyer E.W., Shannon M. The serotonin syndrome. N Engl J Med 2005, 352(11):1112-1120.
25. Eldridge F.L., Paydarfar D., Scott S.C., et al. Role of endogenous adenosine in recurrent generalized seizures. Exp Neurol 1989, 103:179-185.
26. Young D., Dragunow M. Status epilepticus may be caused by loss of adenosine anticonvulsant mechanisms. Neuroscience 1994, 58:245-261.
27. Shannon M., Maher T. Anticonvulsant effects of intracerebroventricular Adenocard in theophylline-induced seizures. Ann Emerg Med 1995, 26:65-68.
28. Finkle B.S., McCloskey K.L., Goodman L.S. Diazepam and drug-associated deaths. A survey in the United States and Canada. JAMA 1979, 242:429-434.
29. Greenblatt D.J., Allen M.D., Noel B.J., et al. Acute overdosage with benzodiazepine derivatives. Clin Pharmacol Ther 1977, 21:497-514.
30. Savitt D., Hawkins H., Roberts J. The radiopacity of ingested medications. Ann Emerg Med 1987, 16(3):331-339.
31. Spivey W.H. Flumazenil and seizures: analysis of 43 cases. Clin Ther 1992, 14(2):292-305.
32. Marchant B., Wray R., Leach A., et al. Flumazenil causing convulsions and ventricular tachycardia. BMJ 1989, 299(6703):860.
33. Hoffman R.S., Goldfrank L.R. The poisoned patient with altered consciousness. Controversies in the use of a 'coma cocktail'. JAMA 1995, 274(7):562-569.
34. Mann J. Murder, magic and medicine 1995, Oxford University Press, Oxford, England.
35. Sneader W. The discovery of heroin. Lancet 1998, 352:1697-1699.
36. Buajordet I., Naess A.C., Jacobsen D., et al. Adverse events after naloxone treatment of episodes of suspected acute opioid overdose. Eur J Emerg Med 2004, 11:19-23.
37. Moeller K.E., Lee K.C., Kissack J.C. Urine drug screening: practical guide for physicians. Mayo Clin Proc 2008, 83(1):66-76.
38. Schumann H., Erickson T., Thompson T., et al. Fentanyl epidemic in Chicago, Illinois, and surrounding Cook County. Clin Toxicol (Phila) 2008, 46(6):501-506.
39. Armstrong P.J., Bersten A. Normeperidine toxicity. Anesth Analg 1986, 65(5):536-538.
40. Sloth Madsen P., Strom J., Reiz S., et al. Acute propoxyphene self-poisoning in 222 consecutive patients. Acta Anaesthesiol Scand 1984, 28(6):661-665.
41. Miller P.L., Gay G.R., Ferris K.C., et al. Treatment of acute, adverse psychedelic reactions: " I've tripped and I can't get down" . J Psychoactive Drugs 1992, 24(3):277-279.
42. Klock J.C., Boerner U., Becker C.E. Coma, hyperthermia, and bleeding associated with massive LSD overdose. Clin Toxicol 1975, 8:191.
43. Nolte K.B., Zumwalt R.E. Fatal peyote ingestion associated with Mallory-Weiss lacerations. West J Med 1999, 170:328.
44. Curry S.C., Rose M.C. Intravenous mushroom poisoning. Ann Emerg Med 1985, 14:900-902.
45. Franz M., Regele H., Kirchmair M., et al. Magic mushrooms: hope for a cheap high resulting in end-stage renal failure. Nephrol Dial Transplant 1996, 11:2324-2327.
46. Lyttle T., Goldstein D., Gartz J. Bufo toads and bufotenine: fact and fiction surrounding an alleged psychedelic. J Psychoactive Drugs 1996, 28:267-290.
47. Kostakis C., Byard R.W. Sudden death associated with intravenous injections of toad extract. Forensic Sci Int 2009, 188:e1-e5.
48. Brubacher J.R., Lachmanen D., Ravikumar, et al. Efficacy of digoxin specific Fab fragments (Digibind) in the treatment of toad venom poisoning. Toxicon 1999, 37:931-942.
49. McKenna A., Nordt S.P., Ryan J. Acute nutmeg poisoning. Eur J Emerg Med 2004, 11:240-241.
50. Roth B.L., Baner K., Westkaemper R., et al. Salvinorin A: a potent naturally occurring nonnitrogenous kappa opioid selective agonist. Proc Natl Acad Sci U S A 2002, 99:11934-11939.
51. Singh S. Adolescent salvia substance abuse. Addiction 2007, 102:823-824.
52. Callaway C.W., Johnson M.P., Gold L.H., et al. Amphetamine derivatives induce locomotor hyperactivity by acting as indirect serotonin agonists. Psychopharmacology 1991, 104:293-301.
53. Ajaelo I., Koenig K., Snoey E. Severe hyponatremia and inappropriate antidiuretic hormone secretion following ecstasy use. Acad Emerg Med 1998, 5:839-840.
54. Caldicott D.G., Edwards N.A., Kruys A., et al. Dancing with " death": p-methoxyamphetamine overdose and its acute management. J Toxicol Clin Toxicol 2003, 41:143-154.
55. Andreasen M.F., Telving R., Birkler R., et al. A fatal poisoning involving bromo-dragonfly. Forensic Sci Int 2009, 183:91-96.
56. Wong E.H., Kemp J.A. Sites for antagonism of N-methyl-D-aspartate receptor channel complex. Annu Rev Pharmacol Toxicol 1991, 31:401-424.
57. McCarron M.M., Schulze B.W., Thompson G.A., et al. Acute phencyclidine intoxications: incidence of clinical findings in 1,000 cases. Ann Emerg Med 1981, 10:237.
58. Jansen K.L. Non-medicinal use of ketamine. BMJ 1993, 306:601-602.
59. Bryant S.M., Kolodchak J. Serotonin syndrome resulting from an herbal detox cocktail. Am J Emerg Med 2004, 22:625-626.
60. Kilpatrick D.G., Edmonds C.N., Seymour A. Rape in America: a report to the nation 1992, National Center for Victims of Crime and Crime Victims Research and Treatment Center, Arlington (VA).
61. Negrusz A., Juhascik M., Gaensslen R.E. Estimate of the incidence of drug facilitated sexual assault in the U.S. Report no. NCJ 212000 2005, U.S. Department of Justice, Washington, DC.
62. Lev R., Clark R.F. Visine overdose: case report of an adult with hemodynamic compromise. J Emerg Med 1995, 13:649-652.
63. Jensen P., Edgren B., Hall L., et al. Hemodynamic effects following ingestion of an imidazoline-containing product. Pediatr Emerg Med 1989, 5:110-112.